©2024 Stanford Medicine
Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing
Not Recruiting
Trial ID: NCT03270722
Purpose
FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has
never been evaluated in patients with scleroderma. The investigators hope to evaluate this
technology in patients who have scleroderma and various esophageal symptoms, and compare to
non-scleroderma patients.
Official Title
Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma
Stanford Investigator(s)
John Clarke
Clinical Professor, Medicine - Gastroenterology & Hepatology
Nielsen Fernandez-Becker
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Lorinda Chung
Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology
Eligibility
Inclusion Criteria:
- Must have a clinical indication for upper endoscopy (recruiting patients both with
scleroderma and without)
Exclusion Criteria:
- not healthy enough to undergo an upper endoscopy
- mass, stricture, ring, or web present on upper endoscopy
- history of esophageal cancer
- history of esophageal surgery
Intervention(s):
device: FLIP topography
procedure: Upper Endoscopy
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
John O Clarke, MD
650-736-5555